Clinical Trials in Herlev, Denmark
3 recruiting
Showing 1–8 of 8 trials
Recruiting
Phase 3
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Triple-Negative Breast Cancer
Merck Sharp & Dohme LLC1,530 enrolled281 locationsNCT06393374
Recruiting
Not Applicable
FDG-PET/CT vs. CT for Monitoring Metastatic Breast Cancer
Metastatic Breast CancerResponse Monitoring
Odense University Hospital420 enrolled11 locationsNCT06877949
Recruiting
DESTINY Breast Respond HER2-low Europe
Metastatic Breast CancerUnresectable Breast CancerHER2-low Expressing Breast Cancer
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company1,155 enrolled211 locationsNCT05945732
Recruiting
Not Applicable
Imaging Versus Cardiac Biomarker Monitored HER2 Directed Therapy in Patients With Breast Cancer
HER2-positive Breast CancerCardiotoxicity
Odense University Hospital220 enrolled4 locationsNCT05406635
Recruiting
Phase 1Phase 2
Study of DF1001 in Patients with Advanced Solid Tumors
Solid Tumor, Adult
Dragonfly Therapeutics378 enrolled52 locationsNCT04143711
Recruiting
Not Applicable
Prospective Surveillance for Breast Cancer-Related Lymphedema
Breast Cancer
Rigshospitalet, Denmark250 enrolled3 locationsNCT04522648
Recruiting
Not Applicable
Partial Breast Versus no Irradiation for Women With Early Breast Cancer
Local Neoplasm RecurrenceDistantly Metastatic Malignant NeoplasmDeath+6 more
Danish Breast Cancer Cooperative Group926 enrolled17 locationsNCT03646955
Recruiting
Not Applicable
The DBCG Proton Trial: Photon Versus Proton Radiation Therapy for Early Breast Cancer
Early Breast CancerRadiation Associated Cardiac Failure
Danish Breast Cancer Cooperative Group1,502 enrolled8 locationsNCT04291378